| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |